Loading...
Loading...
Among the 3 tracked institutional investors we monitor, DRTS (ALPHA TAU MEDICAL LTD) is held with a combined value of $1.32M across 186,132 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $992.59K (0.00% of their portfolio). BlackRock, Inc. opened a new position in the most recent quarter. 2 funds increased their holdings.
Total Institutional Value
$1.32M
Total Shares Held
186,132
Institutional Holders
3
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $992.59K | 0.00% | +457.1% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $286.03K | 0.00% | +0.0% |
| 3 | BlackRock, Inc. | $37.33K | 0.00% | New |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of DRTS with a position worth $992.59K, representing 0.00% of their portfolio. In total, 3 institutional investors hold DRTS with a combined value of $1.32M.
In the most recent quarter, 1 fund opened a new position in DRTS. Additionally, 2 increased their holdings.
Institutional investors hold $1.32M worth of DRTS stock across 3 positions. The largest institutional holder is CITADEL ADVISORS LLC with $992.59K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For DRTS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their DRTS positions.